JPWO2019074826A5 - - Google Patents
Info
- Publication number
- JPWO2019074826A5 JPWO2019074826A5 JP2020520646A JP2020520646A JPWO2019074826A5 JP WO2019074826 A5 JPWO2019074826 A5 JP WO2019074826A5 JP 2020520646 A JP2020520646 A JP 2020520646A JP 2020520646 A JP2020520646 A JP 2020520646A JP WO2019074826 A5 JPWO2019074826 A5 JP WO2019074826A5
- Authority
- JP
- Japan
- Prior art keywords
- dolutegravir
- tablet
- lamivudine
- layer
- microcrystalline cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025120922A JP2025165977A (ja) | 2017-10-13 | 2025-07-18 | 二層医薬錠剤製剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762571863P | 2017-10-13 | 2017-10-13 | |
| US62/571,863 | 2017-10-13 | ||
| US201862634317P | 2018-02-23 | 2018-02-23 | |
| US62/634,317 | 2018-02-23 | ||
| PCT/US2018/054825 WO2019074826A2 (en) | 2017-10-13 | 2018-10-08 | FORMULATION OF BICOLET PHARMACEUTICAL TABLET |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120922A Division JP2025165977A (ja) | 2017-10-13 | 2025-07-18 | 二層医薬錠剤製剤 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020536931A JP2020536931A (ja) | 2020-12-17 |
| JP2020536931A5 JP2020536931A5 (https=) | 2025-09-11 |
| JPWO2019074826A5 true JPWO2019074826A5 (https=) | 2025-09-11 |
| JP7774958B2 JP7774958B2 (ja) | 2025-11-25 |
Family
ID=66101717
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020520646A Active JP7774958B2 (ja) | 2017-10-13 | 2018-10-08 | 二層医薬錠剤製剤 |
| JP2025120922A Pending JP2025165977A (ja) | 2017-10-13 | 2025-07-18 | 二層医薬錠剤製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120922A Pending JP2025165977A (ja) | 2017-10-13 | 2025-07-18 | 二層医薬錠剤製剤 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20200230141A1 (https=) |
| EP (2) | EP4667003A3 (https=) |
| JP (2) | JP7774958B2 (https=) |
| KR (2) | KR20200070246A (https=) |
| CN (2) | CN117281788A (https=) |
| AU (1) | AU2018347990B2 (https=) |
| BR (1) | BR112020006783A2 (https=) |
| CA (1) | CA3078624A1 (https=) |
| CL (1) | CL2020000959A1 (https=) |
| ES (1) | ES3056013T3 (https=) |
| FI (1) | FI3694522T3 (https=) |
| IL (1) | IL273704B2 (https=) |
| MX (1) | MX2020003377A (https=) |
| PL (1) | PL3694522T3 (https=) |
| PT (1) | PT3694522T (https=) |
| TW (1) | TWI841539B (https=) |
| WO (1) | WO2019074826A2 (https=) |
| ZA (1) | ZA202002263B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3920927A1 (en) * | 2019-02-05 | 2021-12-15 | VIIV Healthcare Company | Method for treating hiv with dolutegravir and lamivudine |
| WO2021116244A1 (en) * | 2019-12-12 | 2021-06-17 | Sandoz Ag | Modulation of drug release and bioavailability of compositions containing dolutegravir sodium and other anti hiv drugs |
| CN111991558B (zh) * | 2020-08-28 | 2022-08-09 | 安徽贝克生物制药有限公司 | 一种抗逆转录病毒药物组合物及其制备方法 |
| CN114191404B (zh) * | 2022-01-10 | 2023-06-27 | 安徽贝克生物制药有限公司 | 一种多替拉韦片剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2744019C (en) | 2008-12-11 | 2017-03-14 | Shionogi & Co., Ltd. | Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates |
| US9713622B2 (en) * | 2009-11-20 | 2017-07-25 | Université Versailles Saint-Quentin-En-Yvelines | Schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (HIV) |
| PE20121524A1 (es) * | 2010-01-27 | 2012-12-03 | Viiv Healthcare Co | Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos |
| US20170189402A1 (en) * | 2012-03-28 | 2017-07-06 | Abbvie Inc. | Solid dosage forms |
| CA2885763C (en) * | 2012-10-23 | 2021-04-06 | Cipla Limited | Pharmaceutical antiretroviral composition |
| WO2014184553A1 (en) | 2013-05-15 | 2014-11-20 | Cipla Limited | Pharmaceutical antiretroviral compositions |
| US10189860B2 (en) * | 2014-07-29 | 2019-01-29 | Lek Pharmaceuticals D.D. | Hydrates of dolutegravir sodium |
| CN106860464A (zh) * | 2017-02-16 | 2017-06-20 | 江苏艾迪药业有限公司 | 用于联合抗病毒治疗的药物组合物及应用 |
-
2018
- 2018-10-08 FI FIEP18866268.8T patent/FI3694522T3/fi active
- 2018-10-08 KR KR1020207010456A patent/KR20200070246A/ko not_active Ceased
- 2018-10-08 MX MX2020003377A patent/MX2020003377A/es unknown
- 2018-10-08 AU AU2018347990A patent/AU2018347990B2/en active Active
- 2018-10-08 IL IL273704A patent/IL273704B2/en unknown
- 2018-10-08 PT PT188662688T patent/PT3694522T/pt unknown
- 2018-10-08 WO PCT/US2018/054825 patent/WO2019074826A2/en not_active Ceased
- 2018-10-08 KR KR1020247041200A patent/KR20250004136A/ko active Pending
- 2018-10-08 BR BR112020006783-0A patent/BR112020006783A2/pt unknown
- 2018-10-08 EP EP25212183.5A patent/EP4667003A3/en active Pending
- 2018-10-08 EP EP18866268.8A patent/EP3694522B1/en active Active
- 2018-10-08 CN CN202311269854.5A patent/CN117281788A/zh active Pending
- 2018-10-08 PL PL18866268.8T patent/PL3694522T3/pl unknown
- 2018-10-08 ES ES18866268T patent/ES3056013T3/es active Active
- 2018-10-08 CA CA3078624A patent/CA3078624A1/en active Pending
- 2018-10-08 CN CN201880066314.8A patent/CN111246851A/zh active Pending
- 2018-10-08 JP JP2020520646A patent/JP7774958B2/ja active Active
- 2018-10-08 US US16/652,768 patent/US20200230141A1/en active Pending
- 2018-10-11 TW TW107135747A patent/TWI841539B/zh active
-
2020
- 2020-04-09 CL CL2020000959A patent/CL2020000959A1/es unknown
- 2020-05-04 ZA ZA2020/02263A patent/ZA202002263B/en unknown
-
2025
- 2025-07-18 JP JP2025120922A patent/JP2025165977A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9433620B2 (en) | Pharmaceutical compositions of lurasidone | |
| JPH10147517A (ja) | 高められた崩壊特性を有するフイルムコーテイングされた錠剤組成物 | |
| JP7336388B2 (ja) | 錠剤及びその製造方法 | |
| JP2024028567A (ja) | 固形組成物 | |
| EA024699B1 (ru) | Фармацевтическая таблетка с немедленным высвобождением, содержащая севеламера карбонат | |
| AU2014227598B2 (en) | Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof | |
| JP2025165977A (ja) | 二層医薬錠剤製剤 | |
| JPH05246861A (ja) | ポリカルボフィルカルシウム含有製剤 | |
| CN105407925A (zh) | 用于泡腾剂型的制造工艺 | |
| HU228823B1 (en) | Swallowable tablets with high content of n-acetylcysteine | |
| EP1691790A1 (en) | Sustained release torsemide dosage forms | |
| JP4185974B2 (ja) | カリウム、ナトリウムおよびトリスオキサプロジン塩医薬組成物 | |
| WO2009084041A4 (en) | Pharmaceutical compositions of dexibuprofen | |
| WO2023168295A1 (en) | Therapeutic compounds, formulations, and use thereof | |
| JPWO2019074826A5 (https=) | ||
| PL186915B1 (pl) | Tabletka zawierająca kwas tolfenamowy lub jego farmaceutycznie dopuszczalną sól i sposób wytwarzania takiej tabletki | |
| JP5625262B2 (ja) | 固形製剤 | |
| US20130035344A1 (en) | Pharmaceutical composition for oral administration | |
| JP4719899B2 (ja) | 口腔内速崩壊性錠剤 | |
| TWI651085B (zh) | Ｎ－［５－［２－（３，５－二甲氧基苯基）乙基］－２ｈ－吡唑－３－基］－４－［（３ｒ，５ｓ）－３，５－二甲基哌－１－基］苯甲醯胺之醫藥調配物 | |
| TW202313072A (zh) | 檸檬酸鐵之兒科調配物 | |
| WO2022042646A1 (zh) | 盐酸鲁拉西酮组合物及其制备方法 | |
| US12097185B2 (en) | Compositions comprising ciprofloxacin and celecoxib | |
| US20250170065A1 (en) | Therapeutic compounds, formulations, and use thereof | |
| JP7423297B2 (ja) | 口腔内崩壊錠およびその製造方法 |